5 research outputs found
MRI and MSCT for the Assessment of Myocardial Function and Viability
MRI is a versatile non-invasive imaging modality that can be applied in patients and
in experimental models of ischemic heart disease. MR
Chronic pseudoaneurysm of the left ventricle
We present a case of a 55-year-old men who suffered a silent myocardial infarction four years earlier and presented with exertional dyspnoea. Cardiac magnetic resonance imaging (CMR) and Multislice computed tomography (MSCT) was performed and revealed a giant pseudoaneursym of the lateral wall of the left ventricle with the presence of a thrombus in the lateral wall of the pseudoaneursym. We present this case since excellent non-invasive evaluation of the pseudoaneursym was feasible using state-of-the-art imaging modalities. Information on left ventricular geometry and function as well as myocardial viability and coronary anatomy is available when both MSCT and CMR are performed. This combined approach of these two imaging modalities provide clinically relevant information and may guide therapeutic decision making
Recovery of left ventricular function after primary angioplasty for acute myocardial infarction.
AIMS: To study recovery of segmental wall thickening (SWT), ejection fraction (EF), and end-systolic volume (ESV) after acute myocardial infarction (AMI) in patients who underwent primary stenting with drug-eluting stents. Additionally, to evaluate the predictive value of magnetic resonance imaging (MRI)-based myocardial perfusion and delayed enhancement (DE) imaging. METHODS AND RESULTS: Twenty-two patients underwent cine-MRI, first-pass perfusion, and DE imaging 5 days after successful placement of a drug-eluting stent in the infarct-related coronary artery. Regional myocardial perfusion and the transmural extent of DE were evaluated. A per patient perfusion score was calculated and consisted of a summation of all segmental scores. Myocardial infarct size was quantified by measuring the volume of DE. At 5 months after AMI, cine-MRI was performed and SWT, EF, and ESV were quantified. EF increased from 48+/-11 to 55+/-9% (P<0.01). SWT at 5 months was inversely related to baseline segmental DE scores (P<0.001) and segmental perfusion scores (P<0.001). EF and ESV at 5 months were related to acute infarct size (R(2)=0.65; P<0.001 and R(2)=0.78; P<0.001, respectively) and the calculated perfusion score (R(2)=0.23; P=0.02 and R(2)=0.14; P=0.09, respectively) at baseline. CONCLUSION: Marked recovery of left ventricular function was observed in patients receiving a drug-eluting stent for AMI. DE imaging appears to be a better prognosticator than perfusion imaging
Late cardiac remodeling after primary percutaneous coronary intervention: Five-year cardiac magnetic r
Background: Primary percutaneous coronary intervention (PPCI) preserves function and improves survival. The
late effects of PPCI on left ventricular remodeling, however, have not yet been investigated on cardiac magnetic
resonance imaging (CMRI).
Methods and Results: Twenty-five patients with acute myocardial infarction (AMI) treated with PPCI underwent
CMRI within 10 days, at 4 months and at 5 years. Left ventricular ejection fraction (LVEF), end-diastolic volume
(EDV) and end-systolic volume were quantified on cine images. Infarct mass and transmural extent of infarction were
quantified on contrast-enhanced imaging. In all patients EDV increased significantly in the early phase (192±40ml
to 211±49ml, P≤0.01) and LVEF improved significantly (42±9% to 46±9%, P=0.02). In the late phase (>4 months)
no significant changes were observed (LVEF 44±9%, P=0.07; EDV 216±68ml, P=0.38). Three different groups could
be identified. One-third (32%) had no dilatation at all; one-third (32%) had limited dilatation at 4 months without
progression later; and 36% had progressive dilatation both at 4 months and at late follow-up. This third group had
an average increase in EDV of 20% in the acute phase followed by an additional 13%. The strongest predictor for
progressive dilatation was infarct mass.
Conclusions: Even in the era of PPCI for AMI followed by optimal medical therapy, one-third of patients had progressive dilatation, which was best predicted by infarct mass.   (Circ J 2013; 77: 81–88